| Pharmaceutical Information |
| Drug Name |
Dimercaprol |
| Drug ID |
BADD_D00677 |
| Description |
Dimercaprol is a traditional chelating agent developed by British biochemists at Oxford University during World War II. It was developed as an experimental antidote against the arsenic-based poison gas Lewisite. It has been used clinically since 1949 in arsenic, cadmium and mercury poisoning. In addition, it has in the past been used for the treatment of Wilson's disease, a genetic disorder in which the body tends to retain copper. Dimercaprol has toxic potential, and its use may be followed by a variety of adverse effects. |
| Indications and Usage |
For the treatment of arsenic, gold and mercury poisoning. Indicated in acute lead poisoning when used concomitantly with edetate calcium disodium (DB00974). |
| Marketing Status |
approved |
| ATC Code |
V03AB09 |
| DrugBank ID |
DB06782
|
| KEGG ID |
D00167
|
| MeSH ID |
D004112
|
| PubChem ID |
3080
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
17478-526 |
| UNII |
0CPP32S55X
|
| Synonyms |
Dimercaprol | 2,3-Dithiopropan-1-o1 | 2,3 Dithiopropan 1 o1 | British Anti-Lewisite Agent | Anti-Lewisite Agent, British | British Anti Lewisite Agent | 2,3-Dimercaptopropanol | 2,3 Dimercaptopropanol | British Anti-Lewisite | Anti-Lewisite, British | British Anti Lewisite | Dicaptol | Cadmium 2,3-Dimercaptopropanol | 2,3-Dimercaptopropanol, Cadmium | Cadmium 2,3 Dimercaptopropanol | BAL in Oil | Oil, BAL in | in Oil, BAL | B.A.L. |
|
| Chemical Information |
| Molecular Formula |
C3H8OS2 |
| CAS Registry Number |
59-52-9 |
| SMILES |
C(C(CS)S)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
